News

“Do-Re-Mi” may be fundamental to western music, but not to the human brain, suggests a fascinating new study that has assessed the ability of an isolated community of people living in the Bolivian rainforest to recognize musical notes arranged in the western octave structure.

New RNA sequencing-based genetic research conducted at Washington State University's Bear Research, Education, and Conservation Center shows grizzlies express a larger number of genes in preparation for, and during hibernation to cope with such stressors, than do any other species studied.

Researchers have discovered a potential therapeutic target for osteosarcoma – one which is already used to treat psoriasis.

It sounds like science fiction: controlling electronic devices with brain waves. But researchers have developed a new type of electroencephalogram (EEG) electrode that can do just that, without the sticky gel required for conventional electrodes. Even better, the devices work through a full head of hair.

Researchers have improved our standard methods for estimating the dark matter content of the universe through artificial intelligence, using cutting-edge machine learning algorithms for cosmological data analysis that have a lot in common with those used for facial recognition by Facebook and other social media.

Babies born vaginally have different gut bacteria - their microbiome - than those delivered by Caesarean, research has shown.

A toxic cocktail of chemical pollutants in U.S. drinking water could result in more than 100,000 cancer cases, according to a peer-reviewed study from Environmental Working Group.

Redesigning molecules originally developed to treat the skin disease psoriasis could lead to an effective new drug against malaria, according to new study findings.

Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, according to a new study.

Using patient cell lines and tumor-bearing models, researchers have discovered that inhibition of GSK-3, an enzyme involved in many cancer-promoting processes, sensitizes pancreatic cancer cell lines to gemcitabine, the most commonly used chemotherapy.